Teva Pharmaceuticals has levied a similar challenge. In a lawsuit filed Thursday, Teva said Amarin has engaged in “anticompetitive conduct to prevent and delay generic competition” to Vascepa ...
Teva Pharmaceutical Industries ... The case is 1:24-cv-00428, Novartis Pharmaceuticals Corporation v.
Truist Financial Corp. eliminated 1,687 jobs during the first quarter as the third wave of a “sizable reductions in force” that began in September and is projected to cover a 12- to 18-month ...
The pace of job cuts by U.S. employers accelerated again in March, a sign the labor market is starting to deteriorate in the face of ongoing inflation and high interest rates. That is according to ...
Teva Pharmaceuticals (NYSE:TEVA) and Viatris (NASDAQ:VTRS) have reportedly won a new chance to challenge patent covering Johnson and Johnson's (NYSE:JNJ) schizophrenia drug, Invega Sustenna ...
As of 3:10 PM EDT. Market Open. The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared ...
2024--(BUSINESS WIRE)--Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and mAbxience, a Fresenius Kabi majority-owned group with ...
A Teva spokesperson said the company was pleased with the decision and looks forward to "providing this important low-cost medication to patients as soon as possible." Representatives for Viatris ...
On April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a ...
Defence Secretary Grant Shapps said it was “reasonable” to cut 72,000 civil service jobs to fund Rishi Sunak’s pledge to boost defence spending to 2.5 percent of gross domestic product by 2030.
Teva Pharmaceutical Industries, an Israeli multinational pharmaceutical company, was hit with a patent infringement lawsuit on April 8 in Delaware District Court. The court action, asserting 12 ...